Novartis: Difference between revisions
CSV import |
CSV import |
||
| Line 32: | Line 32: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Novartis-Logo.svg|Novartis Logo | |||
File:Novartis K25 Basel.jpg|Novartis K25 Basel | |||
File:Sandoz-Logo.svg|Sandoz Logo | |||
File:Novartis.jpg|Novartis | |||
File:Novartis Hyderabad office.jpg|Novartis Hyderabad Office | |||
File:Novartis 100 Technology Square Cambridge November 2019.jpg|Novartis 100 Technology Square Cambridge | |||
File:REPORT White House Access for Sale Michael Cohen and Novartis.pdf|Report White House Access for Sale Michael Cohen and Novartis | |||
</gallery> | |||
Latest revision as of 01:17, 20 February 2025
Novartis is a multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies in the world.
History[edit]
Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace back more than 250 years, with a rich history of developing innovative products. From the beginning, Novartis has been driven by a desire to improve and extend people's lives.
Products[edit]
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. The company's portfolio includes medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines, over-the-counter and animal health products.
Research and Development[edit]
Novartis is a global leader in research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.
See Also[edit]
References[edit]
<references />


